CN1251687C - 用于治疗黄病毒科病毒感染之医药组合物、套组、及包装产品 - Google Patents

用于治疗黄病毒科病毒感染之医药组合物、套组、及包装产品 Download PDF

Info

Publication number
CN1251687C
CN1251687C CNB031386946A CN03138694A CN1251687C CN 1251687 C CN1251687 C CN 1251687C CN B031386946 A CNB031386946 A CN B031386946A CN 03138694 A CN03138694 A CN 03138694A CN 1251687 C CN1251687 C CN 1251687C
Authority
CN
China
Prior art keywords
virus
pharmaceutical composition
flaviviridae
treating
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB031386946A
Other languages
English (en)
Chinese (zh)
Other versions
CN1483413A (zh
Inventor
徐祖安
蔡渊钦
黄德仁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Health Research Institutes
Original Assignee
National Health Research Institutes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Health Research Institutes filed Critical National Health Research Institutes
Publication of CN1483413A publication Critical patent/CN1483413A/zh
Application granted granted Critical
Publication of CN1251687C publication Critical patent/CN1251687C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
CNB031386946A 2002-06-03 2003-06-03 用于治疗黄病毒科病毒感染之医药组合物、套组、及包装产品 Expired - Fee Related CN1251687C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38503102P 2002-06-03 2002-06-03
US60/385,031 2002-06-03

Publications (2)

Publication Number Publication Date
CN1483413A CN1483413A (zh) 2004-03-24
CN1251687C true CN1251687C (zh) 2006-04-19

Family

ID=29550193

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB031386946A Expired - Fee Related CN1251687C (zh) 2002-06-03 2003-06-03 用于治疗黄病毒科病毒感染之医药组合物、套组、及包装产品

Country Status (7)

Country Link
EP (1) EP1369120B1 (https=)
JP (1) JP2004131466A (https=)
KR (1) KR20030094097A (https=)
CN (1) CN1251687C (https=)
AT (1) ATE353658T1 (https=)
DE (1) DE60311702T2 (https=)
TW (1) TWI274585B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090058423A (ko) * 2007-12-04 2009-06-09 심형섭 소디움 메타아르세나이트를 함유하는 ｃ형 바이러스성 간염치료용 조성물
RU2518314C2 (ru) * 2012-08-30 2014-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Способ и средство активации irf-3 для лечения и профилактики заболеваний, вызываемых (+) phk-содержащими вирусами
TWI605822B (zh) * 2015-04-09 2017-11-21 高雄醫學大學 酪梨萃取物、ａｖｏｃａｄｅｎｏｌ Ｂ及（２Ｒ，４Ｒ）－１，２，４－三羥基十七碳－１６－炔的用途，以及包含酪梨萃取物之保健食品
EP3815699A1 (en) * 2019-10-28 2021-05-05 Technische Universität München New means and methods for therapy and diagnosis of adenoviral infection
IL295648A (en) * 2020-02-16 2022-10-01 Komipharm Int Australia Pty Ltd treatment method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9214419D0 (en) * 1992-07-07 1992-08-19 Concannon Peter Biocidal agents
JPH0769903A (ja) * 1993-07-01 1995-03-14 Hatsuchiyou:Kk 抗ヒト免疫不全ウイルス剤およびエイズ治療薬
WO1995011033A1 (en) * 1993-10-22 1995-04-27 Commonwealth Scientific And Industrial Research Organisation Polyoxometallates in the treatment of flavivirus infections
FR2786103A1 (fr) * 1998-10-30 2000-05-26 Assist Publ Hopitaux De Paris Utilisation de trioxyde d'arsenic pour la preparation d'un medicament destine a traiter les affections neoplastiques du tissu hematopoietique chez un mammifere et nouvelle composition pharmaceutique
JP4420997B2 (ja) * 1999-02-08 2010-02-24 利博 山瀬 抗ウィルス剤
AU4463300A (en) * 1999-04-19 2000-11-02 Schering Corporation Hcv combination therapy, containing ribavirin in association with antioxidants
JP2001233719A (ja) * 1999-12-13 2001-08-28 Natl Inst Of Advanced Industrial Science & Technology Meti 殺菌材および殺菌方法
WO2001049302A1 (en) * 2000-01-06 2001-07-12 Marantech Holding, Llc Compositions and methods for facilitating skin growth and managing skin conditions
US7744867B2 (en) * 2001-05-31 2010-06-29 The Cleveland Clinic Foundation PTPase inhibitors and method of using same

Also Published As

Publication number Publication date
JP2004131466A (ja) 2004-04-30
DE60311702D1 (de) 2007-03-29
DE60311702T2 (de) 2007-10-31
EP1369120A1 (en) 2003-12-10
CN1483413A (zh) 2004-03-24
TW200307558A (en) 2003-12-16
ATE353658T1 (de) 2007-03-15
KR20030094097A (ko) 2003-12-11
TWI274585B (en) 2007-03-01
EP1369120B1 (en) 2007-02-14

Similar Documents

Publication Publication Date Title
JP5539363B2 (ja) インターフェロンおよびリバビリンとのｈｃｖｎｓ３プロテアーゼ阻害剤の組合せ
JP5869469B2 (ja) 鉄が病因に関与する肝臓疾患の処置
JP2012514606A (ja) Ｈｃｖ治療のためのシクロスポリン誘導体およびヌクレオシドの配合
JP2012502956A (ja) Ｈｃｖの大環状阻害剤とヌクレオシドの相乗性組み合わせ剤
CN1271292A (zh) 灭除慢性丙型肝炎感染患者可检测的hcv－rna的联合治疗
WO2010031832A2 (en) Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
CA2853495A1 (en) Methods and compositions for treating hepatitis c virus
JP2013508425A (ja) Ｂｉ２０１３３５、インターフェロンアルファおよびリバビリンを含むｈｃｖの併用療法のための投薬処置計画
CN1251687C (zh) 用于治疗黄病毒科病毒感染之医药组合物、套组、及包装产品
CN101035555A (zh) 包含栗精胺的组合抗病毒组合物及其使用方法
CN101076338A (zh) Aml的治疗
CN1387438A (zh) 联合化学疗法
JP5989635B2 (ja) Ｈｃｖの大環状阻害剤、非ヌクレオシドおよびヌクレオシドの組合せ
CN101489579A (zh) 病毒性疾病的预防或治疗剂
US20050288258A1 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
CN1093906A (zh) 抗病毒剂
CN104284670B (zh) 用于治疗丙型病毒性肝炎的药剂
JPWO2006033453A1 (ja) インターフェロン作用物質の活性増強剤
JP5527549B2 (ja) Ｃ型肝炎治療剤
JP6656670B2 (ja) 抗ｈｃｖ活性を有する薬剤
JP2017514834A (ja) Ｈｃｖ感染症を治療するための組合せ療法
Buggisch et al. Retreatment of chronic Hepatitis C genotype 1 (G1) infection with Boceprevir (Victrelis®) in the German real-life setting: interim analysis from the non-interventional NOVUS study: 1954
HK1075207A (en) Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060419

Termination date: 20140603